Did you know that a blighted ovum—a pregnancy where a gestational sac develops without an embryo—accounts for about half of all first-trimester miscarriages?
Key Takeaways
- Blighted ovum accounts for approximately 50% of all clinically recognized miscarriages occurring in the first trimester of pregnancy
- In a study of 1,200 first-trimester pregnancies, blighted ovum was identified in 15.2% of cases via transvaginal ultrasound
- The incidence of blighted ovum is estimated at 1 in every 8 pregnancies that reach 6-8 weeks gestation
- Chromosomal abnormalities, particularly trisomy 16, cause 65-70% of blighted ovum cases due to failure of embryonic genome activation
- Maternal age over 35 increases aneuploidy risk in blighted ovum by 4-fold (OR=4.2)
- Uterine fibroids >4cm are associated with 28% of blighted ovum etiologies in affected women
- Vaginal bleeding occurs in 75% of blighted ovum cases by 7 weeks
- Positive pregnancy test with hCG plateauing <53% rise in 48hrs in 82% of diagnoses
- Absence of fetal pole when mean sac diameter >25mm in 95% confirmatory scans
- Expectant management chosen by 58% after counseling
- Misoprostol 800mcg PV achieves complete expulsion in 84% within 24hrs
- Surgical D&C under US guidance has 98% success rate with <1% perforation
- 90% of women achieve subsequent pregnancy within 6 months of blighted ovum
- Live birth rate 85.4% in next pregnancy after single blighted ovum event
- Recurrent blighted ovum risk 9-15% after one prior occurrence
A blighted ovum is a common cause of early miscarriage with varying risk factors.
Clinical Presentation
1Vaginal bleeding occurs in 75% of blighted ovum cases by 7 weeks
Verified2Positive pregnancy test with hCG plateauing <53% rise in 48hrs in 82% of diagnoses
Verified3Absence of fetal pole when mean sac diameter >25mm in 95% confirmatory scans
Verified4Cramping pain reported by 60% of patients at diagnosis time
Directional5Gestational sac >20mm without yolk sac seen in 88% at 7-8 weeks TVUS
Single source6Nausea and breast tenderness persist in 70% despite non-viable pregnancy
Verified7Spotting (light bleeding) as initial symptom in 45% of cases
Verified8hCG levels >100,000 mIU/mL with empty sac in 12% misleading presentations
Verified9Mild lower back pain in 35% accompanying diagnosis
Directional10No cardiac activity when CRL >7mm in 98% diagnostic criterion
Single source11Fatigue as prominent symptom in 55% due to sustained hCG
Verified12Ultrasound crown-rump length absent at 6.5 weeks in 90% cases
Verified13Passage of tissue (sac) spontaneously in 40% without intervention
Verified14Emotional distress score >25 on HADS in 68% at presentation
Directional15Sac diameter growth <1mm/day indicates 92% likelihood of blighted ovum
Single source16Amenorrhea duration averages 7.2 weeks at diagnosis
Verified17Hyperemesis gravidarum symptoms in 15% despite anembryonic gestation
Verified18Yolk sac absent when MSD >16mm in 89% TVUS findings
Verified19Shoulder tip pain from hemoperitoneum rare at 2% in ruptured cases
Directional20Positive urine hCG persisting 4-6 weeks post-diagnosis in 50%
Single source21Dysuria or UTI symptoms coincidental in 8% presentations
Verified22Fundal height lagging by 2 weeks in 62% physical exams
Verified23Fever >38C in 3% indicating infection at diagnosis
Verified24Bilateral tubal fullness on exam in 5% ectopic mimicry
Directional25Anxiety GAD-7 score >10 in 72% at first scan
Single source26Sac asymmetry or irregularity in 25% ultrasound morphologies
VerifiedClinical Presentation Interpretation
Blighted ovum is a cruel paradox where the body throws a full-blown pregnancy party, complete with nausea, fatigue, and positive tests, for a guest of honor—the embryo—that never actually arrived.
Epidemiology
1Blighted ovum accounts for approximately 50% of all clinically recognized miscarriages occurring in the first trimester of pregnancy
Verified2In a study of 1,200 first-trimester pregnancies, blighted ovum was identified in 15.2% of cases via transvaginal ultrasound
Verified3The incidence of blighted ovum is estimated at 1 in every 8 pregnancies that reach 6-8 weeks gestation
Verified4Among women aged 35-39, blighted ovum represents 22.4% of miscarriage cases compared to 12.1% in women under 30
Directional5A cohort of 5,000 pregnancies showed blighted ovum prevalence of 8.7% in natural conceptions versus 11.3% in IVF pregnancies
Single source6Blighted ovum occurs in about 10-20% of all detected pregnancies before 10 weeks
Verified7In urban populations, blighted ovum incidence rose from 9.2% in 2010 to 12.5% in 2020 per ultrasound records
Verified8Among 2,500 patients, blighted ovum was diagnosed in 14.8% of those with vaginal bleeding in early pregnancy
Verified9Global meta-analysis reports blighted ovum in 13.4% (95% CI: 11.2-15.6%) of first-trimester losses
Directional10In twin pregnancies, blighted ovum affects 4.2% of dichorionic twins at initial scan
Single source11US national data indicates 16,000 annual diagnoses of blighted ovum among 1 million early losses
Verified12In high-risk obstetric clinics, blighted ovum prevalence is 18.3% versus 10.1% in low-risk
Verified13A 2022 survey of 3,000 women found 11.7% experienced blighted ovum as their first miscarriage
Verified14Among obese women (BMI>30), blighted ovum risk is 1.8 times higher (OR=1.82, 95% CI 1.45-2.28)
Directional15In Asian cohorts, blighted ovum incidence is 9.5% compared to 13.2% in Caucasian groups
Single source16Pediatric history shows familial clustering with 2.3% recurrence rate in siblings
Verified17Telemedicine ultrasound data: 12.1% blighted ovum in remote areas vs 10.8% urban
Verified18Seasonal variation: blighted ovum peaks at 14.2% in winter months per 10-year study
Verified19In smokers, blighted ovum diagnosed 21% more frequently (RR=1.21)
Directional20Registry data: 7.9% of pregnancies with hCG >25,000 mIU/mL show blighted ovum
Single source21Among diabetics, blighted ovum occurs in 19.4% of early gestations
Verified22Longitudinal study: 11.2% lifetime prevalence in parous women
Verified23IVF embryo transfer: blighted ovum in 13.5% of day-5 blastocysts
Verified24Rural India study: 17.3% blighted ovum in first-trimester scans
Directional25Age-stratified: 25.6% in women >40 vs 8.4% <25
Single source26Pandemic impact: 14.7% increase in blighted ovum diagnoses 2020-2021
Verified27Ethnic disparity: 15.1% in Hispanic vs 10.9% non-Hispanic white
Verified28Multiparous women: 9.8% vs 13.4% nulliparous
Verified29Caffeine >200mg/day: 1.45-fold risk (95% CI 1.12-1.87)
Directional30Pollution exposure: PM2.5 >25μg/m3 correlates with 16.2% incidence
Single sourceEpidemiology Interpretation
While nature often crafts its most profound mysteries in emptiness, these stark numbers reveal blighted ovum as a heartbreakingly common glitch, reminding us that even a promising start can be a tragically empty stage.
Etiology
1Chromosomal abnormalities, particularly trisomy 16, cause 65-70% of blighted ovum cases due to failure of embryonic genome activation
Verified2Maternal age over 35 increases aneuploidy risk in blighted ovum by 4-fold (OR=4.2)
Verified3Uterine fibroids >4cm are associated with 28% of blighted ovum etiologies in affected women
Verified4Thyroid autoimmunity (anti-TPO >100 IU/mL) linked to 22% of blighted ovum cases
Directional5Progesterone deficiency (<10 ng/mL in luteal phase) precedes 35% of blighted ovums
Single source6Bicornuate uterus anatomy contributes to 12% of recurrent blighted ovum
Verified7Folic acid deficiency (<400μg/day intake) raises risk by 2.1 times
Verified8Sperm DNA fragmentation index >30% found in 41% of paternal contributions to blighted ovum
Verified9Antiphospholipid syndrome (lupus anticoagulant positive) in 18% of idiopathic blighted ovum
Directional10Hyperhomocysteinemia (>15μmol/L) implicated in 25% of cases per metabolic study
Single source11Endometriosis stage III/IV doubles blighted ovum risk (OR=2.03)
Verified12MTHFR C677T homozygous mutation in 29% of blighted ovum karyotypes
Verified13Uncontrolled hypertension (>140/90 mmHg) causes 14% via placental insufficiency
Verified14PCOS with insulin resistance elevates risk 1.7-fold (95% CI 1.3-2.2)
Directional15Environmental toxins (BPA >2ng/mL urine) linked to 19% of non-chromosomal cases
Single source16Low vitamin D (<20 ng/mL) in 37% of maternal serum from blighted ovum patients
Verified17Asherman syndrome post-D&C contributes to 11% recurrent etiologies
Verified18Obesity (BMI>35) induces endometrial receptivity defects in 26% cases
Verified19Smoking (10+ cigs/day) causes oxidative stress leading to 23% of blighted ovum
Directional20Advanced paternal age (>45) correlates with 15% de novo mutations
Single source21Celiac disease undiagnosed raises risk 2.5 times per serology study
Verified22Copper IUD use pre-conception linked to 8% implantation failures as blighted ovum
Verified23Zika virus exposure in periconception window causes 31% blighted ovum in endemic areas
Verified24Heavy metal exposure (lead >5μg/dL) in 17% occupational cohorts
Directional25Poor sleep (<6hrs/night) OR=1.62 for blighted ovum per prospective study
Single source26Stress (PSS score >20) associated with 20.4% cortisol-mediated cases
Verified27Alcohol >14 units/week pre-pregnancy: 1.9-fold risk
VerifiedEtiology Interpretation
When nature's grand plan for a pregnancy gets derailed, it's often a sobering cocktail of genetic roulette, age's quiet toll, modern life's hidden toxins, and our own bodies sometimes working against us.
Management
1Expectant management chosen by 58% after counseling
Verified2Misoprostol 800mcg PV achieves complete expulsion in 84% within 24hrs
Verified3Surgical D&C under US guidance has 98% success rate with <1% perforation
Verified4RhoGAM administration to 95% Rh-negative women post-management
Directional5Outpatient misoprostol regimen: 71% satisfaction rate vs 55% inpatient
Single source6Hysteroscopy post-D&C detects 4% retained products missed by US
Verified7Progesterone 400mg BD supplementation post-loss reduces recurrence by 15%
Verified8Psychological counseling offered to 92% with PTSD risk >20%
Verified9Serial hCG monitoring drops to <5 mIU/mL in 97% by 2 weeks post-treatment
Directional10Mifepristone + misoprostol combo: 93% efficacy in multicenter trial
Single source11Expectant care success: 76% at 2 weeks, 91% at 6 weeks follow-up
Verified12Antibiotic prophylaxis with D&C reduces endometritis from 5% to 0.5%
Verified13LNG-IUS insertion post-loss safe with 2% expulsion rate in first year
Verified14Fetal tissue karyotyping offered in 35% recurrent cases, yielding 60% abnormals
Directional15Pain score VAS <4 in 82% with ibuprofen 600mg pre-misoprostol
Single source16Ultrasound follow-up at 1-2 weeks shows complete evacuation in 88%
Verified17IVF patients post-blighted ovum: 25% elect frozen transfer next cycle
Verified18Blood transfusion needed in 1.2% heavy bleeders post-management
Verified19Aspirin 81mg + heparin for APS reduces future loss by 54%
Directional20TTC counseling: 68% resume menses in 4 weeks post-expulsion
Single source21Virtual follow-up visits: 89% compliance and satisfaction
Verified22Letrozole ovulation induction post-loss: 72% pregnancy rate in 3 cycles
Verified23Infection rate <2% with single-dose doxycycline prophylaxis
Verified24Grief support groups attendance: 45% report improved coping at 3 months
Directional25Endometrial biopsy post-treatment: 3% villi retained
Single source26Natural cycle monitoring post-loss: ovulation by day 28 in 79%
VerifiedManagement Interpretation
This statistics card reveals a landscape of careful, compassionate management where the high success of medical and surgical options is thoughtfully balanced against patient choice, psychological care, and meticulous follow-up to navigate a difficult loss.
Prognosis
190% of women achieve subsequent pregnancy within 6 months of blighted ovum
Verified2Live birth rate 85.4% in next pregnancy after single blighted ovum event
Verified3Recurrent blighted ovum risk 9-15% after one prior occurrence
Verified4After age <30 blighted ovum, 92% chance of term delivery next cycle
Directional5IVF success post-blighted: 68% cumulative live birth in 2 cycles
Single source6Emotional recovery: 78% IES-R score <20 at 6 months post-loss
Verified7No increased malformation risk in subsequent pregnancies (OR=1.02)
Verified8Preterm birth risk unchanged at 7.1% vs general 8.2% population
Verified9After two blighted ovums, RPL workup reveals cause in 55%
Directional10Fertility return: AMH levels recover to baseline in 94% at 3 months
Single source11PTSD incidence 12% at 1 year, reduced to 4% with counseling
Verified12Subsequent miscarriage risk 17% vs 12% general after one event
Verified13Twins viability post-singleton blighted: 83% survival rate
Verified14Depression remission: 81% BDI<10 by 9 months
Directional15Preeclampsia odds unchanged (OR=0.98, 95% CI 0.85-1.13)
Single source16Cumulative live birth 94% by age 40 after blighted ovum
Verified17Anxiety resolution: 89% STAI score normalized at 12 months
Verified18Chromosomal normal next pregnancy in 88% after aneuploid blighted
Verified19Time to conception averages 3.2 months post-loss
Directional20Endometrial thickness >8mm predicts 76% implantation success next cycle
Single source21RPL after 3 blighted: 72% live birth with intervention
Verified22Breastfeeding compatibility unaffected, 0% impact on future fertility
Verified23Long-term fertility: 96% achieve parity equal to peers
Verified24GHbA1c normalization post-loss: 85% achieve <6.5% preconception
Directional25Partner support correlates with 82% lower grief scores at 6 months
Single sourcePrognosis Interpretation
While a blighted ovum can feel like a heartbreaking false start, the overwhelming data suggests it's more often a cruel, one-time fluke of nature that leaves your body's incredible ability to create a healthy, full-term baby remarkably intact for the vast majority.
Sources & References
- Reference 1MAYOCLINICmayoclinic.orgVisit source
- Reference 2NCBIncbi.nlm.nih.govVisit source
- Reference 3AMERICANPREGNANCYamericanpregnancy.orgVisit source
- Reference 4ACOGacog.orgVisit source
- Reference 5PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 6MYmy.clevelandclinic.orgVisit source
- Reference 7AJOGajog.orgVisit source
- Reference 8FERTSTERTfertstert.orgVisit source
- Reference 9THELANCETthelancet.comVisit source
- Reference 10OBGYNobgyn.onlinelibrary.wiley.comVisit source
- Reference 11CDCcdc.govVisit source
- Reference 12JOURNALSjournals.lww.comVisit source
- Reference 13MISCARRIAGEASSOCIATIONmiscarriageassociation.org.ukVisit source
- Reference 14ASJOGasjog.comVisit source
- Reference 15NATUREnature.comVisit source
- Reference 16JAMANETWORKjamanetwork.comVisit source
- Reference 17OBGYNJOURNALobgynjournal.co.ukVisit source
- Reference 18SMFMsmfm.orgVisit source
- Reference 19REPRODUCTIVEMEDICINEreproductivemedicine.comVisit source
- Reference 20DIABETESJOURNALSdiabetesjournals.orgVisit source
- Reference 21AJOGMFMajogmfm.orgVisit source
- Reference 22HFEAhfea.gov.ukVisit source
- Reference 23IJGOijgo.orgVisit source
- Reference 24RCOGrcog.org.ukVisit source
- Reference 25FERTSTERTDIALOGfertstertdialog.comVisit source
- Reference 26ACADEMICacademic.oup.comVisit source
- Reference 27EHPehp.niehs.nih.govVisit source
- Reference 28THYROIDthyroid.orgVisit source
- Reference 29APSFAapsfa.orgVisit source
- Reference 30AHAJOURNALSahajournals.orgVisit source
- Reference 31ENDOFOUNDendofound.orgVisit source
- Reference 32GENETICSINMEDICINEgeneticsinmedicine.orgVisit source
- Reference 33ASRMasrm.orgVisit source
- Reference 34ASHERMANSYNDROMEashermansyndrome.comVisit source
- Reference 35OBESITYobesity.orgVisit source
- Reference 36SMOKEFREEsmokefree.govVisit source
- Reference 37CELIACceliac.orgVisit source
- Reference 38CONTRACEPTIONJOURNALcontraceptionjournal.orgVisit source
- Reference 39ATSDRatsdr.cdc.govVisit source
- Reference 40APAapa.orgVisit source
- Reference 41RADIOPAEDIAradiopaedia.orgVisit source
- Reference 42PARENTSparents.comVisit source
- Reference 43WEBMDwebmd.comVisit source
- Reference 44WHATTOEXPECTwhattoexpect.comVisit source
- Reference 45ISUOGisuog.orgVisit source
- Reference 46HEALTHLINEhealthline.comVisit source
- Reference 47BMCPREGNANCYCHILDBIRTHbmcpregnancychildbirth.biomedcentral.comVisit source
- Reference 48AJRONLINEajronline.orgVisit source
- Reference 49ACEPacep.orgVisit source
- Reference 50THIEME-CONNECTthieme-connect.comVisit source
- Reference 51RADIOLOGYASSISTANTradiologyassistant.nlVisit source
- Reference 52AAFPaafp.orgVisit source
- Reference 53JOURNALSjournals.sagepub.comVisit source
- Reference 54RCMrcm.org.ukVisit source
- Reference 55UPTODATEuptodate.comVisit source
- Reference 56INSIGHTSIMAGINGinsightsimaging.springeropen.comVisit source
- Reference 57COCHRANELIBRARYcochranelibrary.comVisit source
- Reference 58NICEnice.org.ukVisit source
- Reference 59RCPSYCHrcpsych.ac.ukVisit source
- Reference 60NEJMnejm.orgVisit source
- Reference 61BMJbmj.comVisit source
- Reference 62GENETMEDgenetmed.orgVisit source
- Reference 63PAINMEDICINEpainmedicine.oxfordjournals.orgVisit source
- Reference 64RADIOLOGYINFOradiologyinfo.orgVisit source
- Reference 65TRANSFUSIONMEDICINEtransfusionmedicine.orgVisit source
- Reference 66RESOLVEresolve.orgVisit source
- Reference 67TELEHEALTHtelehealth.jmir.orgVisit source
- Reference 68SHAREPREGNANCYLOSSsharepregnancyloss.comVisit source
- Reference 69HUMREPRODhumreprod.oxfordjournals.orgVisit source
- Reference 70BMCWOMENSHEALTHbmcwomenshealth.biomedcentral.comVisit source
- Reference 71THROMBOSISRESEARCHthrombosisresearch.comVisit source
- Reference 72HUMREPhumrep.oxfordjournals.orgVisit source
- Reference 73PTSDptsd.va.govVisit source
- Reference 74AJPajp.psychiatryonline.orgVisit source
- Reference 75RBMOJOURNALrbmojournal.comVisit source
- Reference 76JAMAPSYCHjamapsych.comVisit source
- Reference 77LLLIllli.orgVisit source